Neisseria Meningitidis Group A Polysaccharide Antigen Uses, Dosage, Side Effects and more

Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.

Attribute	Details
Trade Name	Neisseria Meningitidis Group A Polysaccharide Antigen
Generic	Meningococcal polysaccharide vaccine group A
Meningococcal polysaccharide vaccine group A Other Names	Meningococcal group A polysaccharide, Meningococcal polysaccharide antigen group A, Neisseria meningitidis group A capsular polysaccharide antigen, Neisseria meningitidis group A polysaccharide antigen, A
Type
Groups	Approved, Experimental, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph